What is Y.S.P. Southeast Asia Holding Bhd Gross Margin %?
Y.S.P. Southeast Asia Holding BhdXKLS:7178 82 Gross Margin % is 42.17% as of Mar. 2026, which is 4% below its 10-year median of 43.78. GuruFocus rates XKLS:7178 with a GF Score™ of 82/100 and a GF Value™ of RM2.40 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 937 Drug Manufacturers companies, Y.S.P. Southeast Asia Holding Bhd ranks worse than 57.95% on this metric.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Y.S.P. Southeast Asia Holding Bhd had a gross margin of 42.17% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Y.S.P. Southeast Asia Holding Bhd Gross Margin % Related Terms
Y.S.P. Southeast Asia Holding Bhd Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd Gross Margin % Chart
XKLS:7178 vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a Gross Margin % of 42.17% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is near median its historical median of 43.78. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's Gross Margin % has ranged from 39.62 to 46.90. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #543 out of 937 companies in the Drug Manufacturers industry, placing it in the top 58%.
Is Y.S.P. Southeast Asia Holding Bhd's Gross Margin % too high?
Y.S.P. Southeast Asia Holding Bhd's current Gross Margin % of 42.17% is near median its 10-year median of 43.78. Over the past 10 years, this metric has ranged from a low of 39.62 to a high of 46.90. The Drug Manufacturers industry median Gross Margin % is 48.46. Y.S.P. Southeast Asia Holding Bhd's value of 42.17% is 13% below this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #543 out of 937 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #543 out of 937 companies for Gross Margin %. This places Y.S.P. Southeast Asia Holding Bhd in the lower half of its industry. The industry median Gross Margin % is 48.46. Y.S.P. Southeast Asia Holding Bhd's value of 42.17% is 13% below this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own Gross Margin % has ranged from 39.62 to 46.90 over the past decade. While the company's 10-year median is 43.78 vs. the industry median of 48.46, Y.S.P. Southeast Asia Holding Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current Gross Margin % of 42.17% is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current Gross Margin % is 42.17%, which is near median its own 10-year median of 43.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.04 — trading 15% below its estimated fair value. The current Gross Margin % is 42.17%, which is near median its 10-year median of 43.78 and 13% below the Drug Manufacturers industry median of 48.46. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current Gross Margin % is 42.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.04 is trading 15% below its estimated GF Value™ of RM2.40.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
Gross Margin %: 42.17% (near median its 10-year median of 43.78)
GF Value™: RM2.40 vs. price of RM2.04 (15% below fair value)
Industry Position: 13% below the Drug Manufacturers median (#543 of 937)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
82GF Score
Get the complete analysis for XKLS:7178
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
